Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ05
- Pharmacological subgroupJ05A
- Chemical subgroupJ05AB
- Chemical substanceJ05AB17Brincidofovir
Where it is registered
Each register with its number of medicines and a few of them.
All medicines with Brincidofovir
Every register, a page at a time. Strengths and packs are on each medicine’s page.
5 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Tembexa | United States | 10MG/ML | suspension | Marketed | Emergent Biodefense |
| Tembexa | United States | 100MG | tablet | Marketed | Emergent Biodefense |
| Tembexa | Canada | 10 MG / ML | Suspension | Authorised | Emergent Biodefense Operations Lansing LLC |
| Tembexa | Canada | 100 MG | Tablet | Authorised | Emergent Biodefense Operations Lansing LLC |
| Cidofovir | United States | 375MG BASE/5ML | solution | Marketed | Mylan Institutional |